Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and...
Cancer
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is...
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
NMDP Unite will be held simultaneously on Sept. 20—World Marrow Donor Day—in Atlanta, Houston, New York, Minneapolis and Seattle Be...
REPEAT — Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) --...
BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
VANCOUVER, BC / ACCESS Newswire / August 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a...
ANGLE Announces Collaboration with Myriad Genetics
Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test...
mPATH Partners with NC Health Centers and DHHS to Expand Colorectal Cancer Screening Access Across the State
Pilot program involving over 10,000 North Carolinians shows early signs of success WINSTON-SALEM, N.C., Aug. 19, 2025 /PRNewswire/ -- mPATH Health,...
Superpower Launches $199 Membership to Help Democratize Concierge-Level Healthcare Nationwide
The health super app delivers advanced biomarker testing, on-demand health guidance, and personalized care plans - all for the annual...
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to...
Real World Evidence Solutions Market worth $10.83 billion by 2030 with 14.8% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Real World Evidence Solutions Market, valued at US$4.74 billion in 2024,...
Calidar Announces Groundbreaking 4D Mammography System: First-in-Human Study Initiated
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 /PRNewswire/ -- Calidar, Inc., an innovative start-up in precision diagnostic imaging, today announced...
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper...
University Hospitals Launches HealthSnap-Powered RPM for Uncontrolled Hypertension Care
CLEVELAND and MIAMI, Aug. 19, 2025 /PRNewswire/ -- HealthSnap, a leading virtual care management company, announced today that University Hospitals (UH),...
New US$ 1 Million Prize Competition Aims to Revolutionize Alzheimer’s Research by Leveraging Agentic AI Systems
SEATTLE, Aug. 19, 2025 /PRNewswire/ -- The Alzheimer's Disease Data Initiative (AD Data Initiative) today launched the Alzheimer's Insights AI Prize |...
Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug. 19, 2025...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers
First-of-its kind tool to guide HCPs on what to consider when staging patients with Mycosis Fungoides and Sézary SyndromePRINCETON, N.J.,...
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company...
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
NEW YORK and CAMBRIDGE, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation...